BioRestorative Therapies (BRTX)
NASDAQ:BRTX
Holding BRTX?
Track your performance easily

BioRestorative Therapies (BRTX) Financial Statements

163 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently ―. The company's EPS TTM is $-1.22; its P/E ratio is -1.36; BioRestorative Therapies is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 89.10K$ 35.00K$ 30.70K$ 64.50K$ 31.30K
Gross Profit$ 82.61K$ 35.00K$ 30.70K$ 64.50K$ 31.30K
EBIT$ -4.20M$ -2.36M$ -3.02M$ -3.08M$ 5.77M
EBITDA$ -4.16M$ -2.32M$ -2.98M$ -3.04M$ 5.80M
Net Income Common Stockholders$ -4.03M$ -3.93M$ -2.93M$ -2.98M$ 5.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 14.68M$ 16.42M$ 12.24M$ 11.62M$ 12.37M
Total Assets$ 16.12M$ 17.95M$ 13.80M$ 13.30M$ 14.08M
Total Debt$ 83.58K$ 123.54K$ 198.72K$ 234.06K$ 268.36K
Net Debt$ -14.60M$ -16.29M$ -12.04M$ -11.38M$ -12.11M
Total Liabilities$ 5.32M$ 3.45M$ 975.03K$ 896.43K$ 593.93K
Stockholders Equity$ 10.80M$ 14.50M$ 12.83M$ 12.40M$ 13.49M
Cash Flow-
Free Cash Flow$ -1.94M$ -2.30M$ -1.19M$ -1.23M$ -2.36M
Operating Cash Flow$ -1.90M$ -2.30M$ -1.18M$ -1.20M$ -2.30M
Investing Cash Flow$ 2.97M$ -4.93M$ -23.06K$ 665.80K$ 2.51M
Financing Cash Flow$ -12.84K$ 7.52M$ 1.85M$ 411.70K-
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis